Montpellier-based SeqOne Genomics gets €20 million boost to make genetic testing more accessible

Published on January 24, 2022

Providing an end-to-end genomic analysis platform, SeqOne Genomics has just landed €20 million in its mission to bring genomic analysis to everyone. ​​The round was led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors Elaia and IRDI Capital Investissement.  The Montpellier-based healthtech company are focusing on the development of state-of-the-art…

This content is for members only. Visit the site and log in/register to read.

The post Montpellier-based SeqOne Genomics gets €20 million boost to make genetic testing more accessible appeared first on EU-Startups.

Continue reading on website
Other news

On Holding AG Stock Could be a New Trend on Many Levels

January 24, 2022
Swiss footwear maker On Holding AG (NYSE: ONON) stock has been cut in half since hitting highs of $55.87 in November 2021.

Sterling Bancorp (SBT) Soars 5.4%: Is Further Upside Left in the Stock?

January 24, 2022
Sterling Bancorp (SBT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...